HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Controlled trials on low-protein diet: effects on chronic renal insufficiency progression.

Abstract
The effect of a low-protein diet (LPD) on chronic renal insufficiency (CRI) progression was investigated by reviewing the published studies. Only three of these fulfilled the main methodological criteria of being randomized, prospective, and controlled: those of Rosman, Ihle and Locatelli. These trials involved 811 patients (671 evaluated: 338 on a LPD, 333 as controls) and had a mean follow-up of 29 months (range 18-48), for an estimated total of about 17,335 patient-months. The only trial whose results showed that LPD had a positive effect on chronic renal failure (CRF) progression was Ihle's study, with the lowest weight (6.7%) and involving the most severe CRF; effects limited to the patients with more advanced CRF were found in the Rosman study, with an intermediate weight (41.8%); and little effect, if any, was found in the Locatelli trial, accounting for 51.5% of patient-months, with less severe CRI. In conclusion, analysis of published randomized, prospective, and controlled trials offers little or no support for the hypothesis that a LPD has a clinically significant effect on the early CRI progression, although a very low protein diet seems to postpone the need for dialysis.
AuthorsF Locatelli, D Marcelli, F Tentori, M C Bigi, P Marai
JournalRenal failure (Ren Fail) Vol. 15 Issue 3 Pg. 407-13 ( 1993) ISSN: 0886-022X [Print] England
PMID8516499 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Review)
Chemical References
  • Dietary Proteins
Topics
  • Adult
  • Dietary Proteins (administration & dosage)
  • Follow-Up Studies
  • Humans
  • Kidney Failure, Chronic (diet therapy, epidemiology)
  • Middle Aged
  • Prospective Studies
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: